Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 9 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B PatientsStatus unknownNCT04480294Phase 1
• A Trial of Famitinib in Patients With Failure of First-Line Treatment For Intrahepatic CholangiocarcinomaWithdrawnNCT04479904Phase 2
• Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy SubjectsCompletedNCT04479891Phase 1
• The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Healthy SubjectsCompletedNCT04472819Phase 1
• Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.Status unknownNCT04470063Phase 1
• Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB SubjectsCompletedNCT04464733Phase 1
• A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor SubjectsCompletedNCT04457180Phase 1
• A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial HypercholesterolemiaStatus unknownNCT04455581Phase 2
• A Phase I Study of SHR1459 in Healthy SubjectsCompletedNCT04455100Phase 1
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based ChemotherapyCompletedNCT04447118Phase 3
• A Study of SHR-A1811 in Subjects With Advanced Malignant Solid TumorsCompletedNCT04446260Phase 1
• A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)CompletedNCT04443751Phase 1
• Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy SubjectsCompletedNCT04439578Phase 1
• A Multiple Dose Study to Evaluate the Effect of SHR-1222 Injection in Postmenopausal Osteoporosis PatientsCompletedNCT04435158Phase 1
• A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.CompletedNCT04428086Phase 1
• Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal CancerStatus unknownNCT04426955Phase 3
• A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic CancerStatus unknownNCT04425876Phase 1
• Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy SubjectsCompletedNCT04423601Phase 1
• The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.CompletedNCT04417972Phase 1/2
• A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal FunctionStatus unknownNCT04414852Phase 1
• A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant TumoursCompletedNCT04414150Phase 1
• Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of ImatinibTerminatedNCT04409223Phase 3
• A Clinical Study of Remimazolam Tosilate in Patients Undergoing BronchoscopyCompletedNCT04400201Phase 3
• A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung CancerCompletedNCT04400188Phase 1/2
• A Bioequivalence Study of Famitinib Malate on Healthy Chinese VolunteersCompletedNCT04400123Phase 1
• A Bioavailability Study of SHR1459 on Healthy Chinese VolunteersCompletedNCT04395053Phase 1
• Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC PatientsStatus unknownNCT04390984Phase 1
• Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 DiabetesStatus unknownNCT04390295Phase 3
• Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian CancerStatus unknownNCT04383977Phase 2
• A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of AdultsCompletedNCT04383418Phase 3
• Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast CancerCompletedNCT04367090Phase 1
• Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid TumorCompletedNCT04346381Phase 2
• A Phase II Study in Patients With Alopecia AreataCompletedNCT04346316Phase 2
• Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin LymphomaStatus unknownNCT04342936Phase 3
• A Food Effect Study of Apatinib Mesylate in Healthy SubjectsCompletedNCT04341090Phase 1
• Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese SubjectsStatus unknownNCT04341077Phase 1
• A Food Effect Study of SHR2554 on Healthy Chinese Male Adult SubjectsCompletedNCT04335266Phase 1
• A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.TerminatedNCT04335006Phase 3
• A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid ArthritisCompletedNCT04333771Phase 3
• A Trial of SHR3162 in Healthy Caucasian VolunteersCompletedNCT04333134Phase 1
• A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy SubjectsStatus unknownNCT04326881Phase 1
• A Trial of SHR-1701 in Subjects With Advanced Solid TumorsCompletedNCT04324814Phase 1
• A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor SubjectsCompletedNCT04322552Phase 1
• A Study of SHR0410 in Hemodialysis Patients With PruritusStatus unknownNCT04317209Phase 1
• Comparison of Analgesic Effect and Prognosis of Butorphanol and Fentanyl in Patients With Mechanical VentilationStatus unknownNCT04315935Phase 4
• Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy ParticipantsStatus unknownNCT04315493Phase 1
• A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib MaleateCompletedNCT04315116Phase 1
• Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic ImpairmentStatus unknownNCT04305392Phase 1
• A Trial of SHR6390 in Healthy Caucasian VolunteersCompletedNCT04301804Phase 1
• A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyTerminatedNCT04300114Phase 3
• Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic ImpairmentCompletedNCT04293029Phase 1
• A Food Effect Study of SHR1459 on Healthy Chinese Adult SubjectsCompletedNCT04291846Phase 1
• SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04282070Phase 1
• Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers.CompletedNCT04260373Phase 1
• A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based ChemotherapyStatus unknownNCT04229615Phase 3
• The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy SubjectsCompletedNCT04229433Phase 1
• A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic CancerCompletedNCT04228601Phase 1/2
• Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04203485Phase 3
• A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of ChildrenCompletedNCT04200235Phase 1
• Food Effect Study of DDO-3055 Tablets in Healthy SubjectsCompletedNCT04197778Phase 1
• Effect of Fluconazole on PK of Fluzoparib in Healthy Male SubjectsCompletedNCT04193319Phase 1
• A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With HyperuricemiaStatus unknownNCT04180982Phase 2
• The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With HyperuricemiaStatus unknownNCT04157959Phase 1
• A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in AdultsSuspendedNCT04121143Phase 2
• Effect of Omeprazole on PK of Fluzoparib in Healthy Male SubjectsCompletedNCT04108676Phase 1
• A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPCStatus unknownNCT04108247Phase 1
• A Study of HR071603(Ketamine Nasal Spray) in Healthy SubjectsCompletedNCT04108234Phase 1
• A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPCTerminatedNCT04102124Phase 2
• A Study of SHR4010 in Patients With HemodialysisCompletedNCT04099927Phase 1
• A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With GoutCompletedNCT04052932Phase 3
• A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer PatientsCompletedNCT04041011Phase 1
• A Study of SHR-1501 in Patients With Advanced TumorsCompletedNCT04025957Phase 1
• Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid TumorCompletedNCT04013048Phase 1
• A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on FluzoparibCompletedNCT04011124Phase 1
• Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian CancerStatus unknownNCT04000295Phase 3
• A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced TumorsCompletedNCT03995472Phase 1
• A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerActive, not recruitingNCT03980054Phase 3
• Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human SubjectsCompletedNCT03977805Phase 1
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.CompletedNCT03976882Phase 3
• A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney DiseaseCompletedNCT03976115Phase 1
• Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild HypertensionCompletedNCT03971929Phase 1
• A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerStatus unknownNCT03966898Phase 3
• A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBCCompletedNCT03945604Phase 1
• The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With HyperlipidemiaCompletedNCT03944109Phase 1/2
• A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast CancerStatus unknownNCT03927456Phase 3
• A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective SurgeryCompletedNCT03921775Phase 3
• A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLCStatus unknownNCT03904823Phase 2
• A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid TumorsTerminatedNCT03871855Phase 1
• The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy SubjectsCompletedNCT03870100Phase 1
• A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer PatientsCompletedNCT03863860Phase 3
• A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast CancerStatus unknownNCT03863223Phase 3
• A Trial of SHR0410 Injection in Hemodialysis Participants.CompletedNCT03857568Phase 1
• A Study of SHR-A1403 in Patients With Advanced Solid TumorCompletedNCT03856541Phase 1
• A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.CompletedNCT03848793Phase 2
• Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological TumorsStatus unknownNCT03827837Phase 2
• Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaCompletedNCT03825744Phase 3
• A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic TherapyCompletedNCT03813784Phase 3
• Study of Remimazolam Tosilate in Patients Undergoing ColonoscopyCompletedNCT03779061Phase 3
• Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung CancerTerminatedNCT03777124Phase 2
• SHR-1701 in Subjects With Metastatic or Locally Advanced Solid TumorsStatus unknownNCT03774979Phase 1

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas